Faster access than browser!
38 relations: Cancer immunotherapy, Celgene, Chemotherapy, Clonal hypereosinophilia, CMML, Colony stimulating factor 1 receptor, Crenolanib, Decitabine, Dwayne Schintzius, Emberger syndrome, Eosinophilic myocarditis, ETV6, Fibroblast growth factor receptor 1, GATA2, GATA2 deficiency, Genesis P-Orridge, Glasdegib, Hypereosinophilia, Index of oncology articles, International Classification of Diseases for Oncology, Janus kinase inhibitor, Lenzilumab, Leukemia, List of acronyms: C, List of diseases (C), List of hematologic conditions, List of medical abbreviations: C, List of therapeutic monoclonal antibodies, Monocytic leukemia, Monocytosis, Myelodysplastic syndrome, Myelomonocyte, Panobinostat, Paul E. Meehl, PDGFRB, Rigosertib, Tet methylcytosine dioxygenase 2, Triciribine.
Cancer immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology, abbreviated IO) is the use of the immune system to treat cancer.
New!!: Chronic myelomonocytic leukemia and Cancer immunotherapy · See more »
Celgene
Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders.
New!!: Chronic myelomonocytic leukemia and Celgene · See more »
Chemotherapy
Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen.
New!!: Chronic myelomonocytic leukemia and Chemotherapy · See more »
Clonal hypereosinophilia
Clonal hypereosinophilia, also termed primary hypereosinophilia or clonal eosinophilia, is a grouping of hematological disorders all of which are characterized by the development and growth of a pre-malignant or malignant population of eosinophils, a type of white blood cell that occupies the bone marrow, blood, and other tissues.
New!!: Chronic myelomonocytic leukemia and Clonal hypereosinophilia · See more »
CMML
CMML may refer to.
New!!: Chronic myelomonocytic leukemia and CMML · See more »
Colony stimulating factor 1 receptor
Colony stimulating factor 1 receptor (CSF1R), also known as macrophage colony-stimulating factor receptor (M-CSFR), and CD115 (Cluster of Differentiation 115), is a cell-surface protein encoded, in humans, by the CSF1R gene (known also as c-FMS).
New!!: Chronic myelomonocytic leukemia and Colony stimulating factor 1 receptor · See more »
Crenolanib
Crenolanib besylate (CP-868,596-26 or AR-868,596-26, 4-piperidinamine, 1--, monobenzenesulfonate) is an investigational inhibitor being developed by AROG Pharmaceuticals, LLC.
New!!: Chronic myelomonocytic leukemia and Crenolanib · See more »
Decitabine
Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor.
New!!: Chronic myelomonocytic leukemia and Decitabine · See more »
Dwayne Schintzius
Dwayne Kenneth Schintzius (October 14, 1968 – April 15, 2012) was an American National Basketball Association (NBA) basketball player.
New!!: Chronic myelomonocytic leukemia and Dwayne Schintzius · See more »
Emberger syndrome
The Emberger syndrome is a rare, autosomal dominant, genetic disorder caused by familial or sporadic inactivating mutations in one of the two parental GATA2 genes.
New!!: Chronic myelomonocytic leukemia and Emberger syndrome · See more »
Eosinophilic myocarditis
Eosinophilic myocarditis is inflammation in the heart muscle that is caused by the infiltration and destructive activity of a type of white blood cell, the eosinophil.
New!!: Chronic myelomonocytic leukemia and Eosinophilic myocarditis · See more »
ETV6
ETV6 (i.e. translocation-Ets-leukemia virus) protein is a transcription factor that in humans is encoded by the ETV6 (previously known as TEL) gene.
New!!: Chronic myelomonocytic leukemia and ETV6 · See more »
Fibroblast growth factor receptor 1
Fibroblast growth factor receptor 1 (FGFR1), also known as basic fibroblast growth factor receptor 1, fms-related tyrosine kinase-2 / Pfeiffer syndrome, and CD331, is a receptor tyrosine kinase whose ligands are specific members of the fibroblast growth factor family.
New!!: Chronic myelomonocytic leukemia and Fibroblast growth factor receptor 1 · See more »
GATA2
GATA2 or GATA-binding factor 2 is a transcription factor, i.e. a nuclear protein which regulates the expression of genes.
New!!: Chronic myelomonocytic leukemia and GATA2 · See more »
GATA2 deficiency
GATA2 deficiency (also termed GATA2 haploinsufficiency or GATA2 deficiency syndrome) is a recently defined grouping of several disorders caused by common defect, viz., familial or sporadic inactivating mutations in one of the two parental GATA2 genes.
New!!: Chronic myelomonocytic leukemia and GATA2 deficiency · See more »
Genesis P-Orridge
Genesis Breyer P-Orridge (born Neil Andrew Megson; 22 February 1950) is an English singer-songwriter, musician, poet, performance artist, and occultist.
New!!: Chronic myelomonocytic leukemia and Genesis P-Orridge · See more »
Glasdegib
Glasdegib (PF-04449913) is an experimental cancer drug developed by Pfizer.
New!!: Chronic myelomonocytic leukemia and Glasdegib · See more »
Hypereosinophilia
Hypereosinophilia is an elevation in an individual's circulating blood eosinophil count above 15.0 x 109/L (i.e. 1,500/μL).
New!!: Chronic myelomonocytic leukemia and Hypereosinophilia · See more »
Index of oncology articles
This is a list of terms related to oncology.
New!!: Chronic myelomonocytic leukemia and Index of oncology articles · See more »
International Classification of Diseases for Oncology
The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases.
New!!: Chronic myelomonocytic leukemia and International Classification of Diseases for Oncology · See more »
Janus kinase inhibitor
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
New!!: Chronic myelomonocytic leukemia and Janus kinase inhibitor · See more »
Lenzilumab
Lenzilumab (INN) (alternative identifier KB003) is a humanized monoclonal antibody (class IgG1 kappa) that targets colony stimulating factor 2 (CSF2)/granulocyte-macrophage colony stimulating factor (GM-CSF) designed for the treatment of chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML).
New!!: Chronic myelomonocytic leukemia and Lenzilumab · See more »
Leukemia
Leukemia, also spelled leukaemia, is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells.
New!!: Chronic myelomonocytic leukemia and Leukemia · See more »
List of acronyms: C
(Main list of acronyms).
New!!: Chronic myelomonocytic leukemia and List of acronyms: C · See more »
List of diseases (C)
This is a list of diseases starting with the letter "C".
New!!: Chronic myelomonocytic leukemia and List of diseases (C) · See more »
List of hematologic conditions
There are many conditions of or affecting the human hematologic system — the biological system that includes plasma, platelets, leukocytes, and erythrocytes, the major components of blood and the bone marrow.
New!!: Chronic myelomonocytic leukemia and List of hematologic conditions · See more »
List of medical abbreviations: C
Category:Lists of medical abbreviations.
New!!: Chronic myelomonocytic leukemia and List of medical abbreviations: C · See more »
List of therapeutic monoclonal antibodies
This is a list of therapeutic, diagnostic and preventive monoclonal antibodies, antibodies that are clones of a single parent cell.
New!!: Chronic myelomonocytic leukemia and List of therapeutic monoclonal antibodies · See more »
Monocytic leukemia
Monocytic leukemia is a type of myeloid leukemia characterized by a dominance of monocytes in the marrow.
New!!: Chronic myelomonocytic leukemia and Monocytic leukemia · See more »
Monocytosis
Monocytosis is an increase in the number of monocytes circulating in the blood.
New!!: Chronic myelomonocytic leukemia and Monocytosis · See more »
Myelodysplastic syndrome
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells.
New!!: Chronic myelomonocytic leukemia and Myelodysplastic syndrome · See more »
Myelomonocyte
A myelomonocyte is a type of cell observed in chronic myelomonocytic leukemia.
New!!: Chronic myelomonocytic leukemia and Myelomonocyte · See more »
Panobinostat
Panobinostat (trade name Farydak) is a drug by Novartis for the treatment of various cancers.
New!!: Chronic myelomonocytic leukemia and Panobinostat · See more »
Paul E. Meehl
Paul Everett Meehl (3 January 1920 – 14 February 2003) was a clinical psychologist and Professor of Psychology at the University of Minnesota.
New!!: Chronic myelomonocytic leukemia and Paul E. Meehl · See more »
PDGFRB
Beta-type platelet-derived growth factor receptor is a protein that in humans is encoded by the PDGFRB gene.
New!!: Chronic myelomonocytic leukemia and PDGFRB · See more »
Rigosertib
Rigosertib (ON-01910 sodium salt, with Estybon as trade name) is a synthetic benzyl styryl sulfone in development by Onconova Therapeutics.
New!!: Chronic myelomonocytic leukemia and Rigosertib · See more »
Tet methylcytosine dioxygenase 2
Tet methylcytosine dioxygenase 2 (TET2) is a human gene.
New!!: Chronic myelomonocytic leukemia and Tet methylcytosine dioxygenase 2 · See more »
Triciribine
Triciribine is a cancer drug which was first synthesized in the 1970s and studied clinically in the 1980s and 1990s without success.
New!!: Chronic myelomonocytic leukemia and Triciribine · See more »
Redirects here:
Chronic myelomonocytic leukaemia.
References
[1] https://en.wikipedia.org/wiki/Chronic_myelomonocytic_leukemia
